Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • WATSON PHARMACEUTICALS INC Analyst Recommendations

  • Analyst Consensus: WPI

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.813 Hold 16
    30 Days Ago 2.813 Hold 16
    60 Days Ago 2.813 Hold 16
    90 Days Ago 2.813 Hold 16
    120 Days Ago 2.824 Hold 17

  • Analyst Ratings: WPI

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    RBC Capital Mkts — Outperform 05/01/2009 39.00
    RBC Capital Mkts — Outperform 04/22/2009 37.00
    Credit Suisse — Neutral 02/25/2009 —
    Citigroup — Hold 02/16/2009 34.00
    Stanford Research Hold Buy 01/22/2009 31.00
    JP Morgan — Neutral 12/17/2008 —
    Roth Capital Buy — 12/15/2008 38.00
    Credit Suisse Neutral Underperform 11/06/2008 23.00
    Stanford Research — Hold 09/25/2008 —
    Needham — Hold 09/24/2008 —
    Wachovia Mkt Perform Outperform 09/22/2008 —
    Roth Capital — Buy 02/25/2008 38.00
    Lehman Brothers — Equal-weight 02/21/2008 33.00
    WR Hambrecht Hold Buy 02/19/2008 —
    Banc of America Sec — Neutral 12/18/2007 31.00
    Roth Capital Hold Buy 09/28/2007 39.00
    Roth Capital — Hold 08/03/2007 34.50
    UBS Neutral Buy 05/02/2007 37.00
    Roth Capital — Hold 05/02/2007 31.00
    Goldman Sachs Sell Neutral 03/26/2007 —
    UBS — Neutral 03/23/2007 27.00
    Roth Capital Buy Hold 02/28/2007 30.00
    Roth Capital — Buy 11/08/2006 30.00
    FTN Midwest — Buy 10/17/2006 —
    Prudential — Underweight 08/07/2006 23.00
    JP Morgan — Underweight 07/19/2006 —
    Credit Suisse — Neutral 06/29/2006 —
    Roth Capital — Buy 06/15/2006 31.00
    Leerink Swann — Outperform 03/02/2006 —
    UBS Reduce Neutral 02/24/2006 30.50
    Next